Cargando…
Increased healthcare costs by later stage cancer diagnosis
BACKGROUND: Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis and treatment of cancer at earlier stages may reduce this burden. To better understand potential impacts of earlier diagnosis, healthcare costs among patients w...
Autores principales: | McGarvey, November, Gitlin, Matthew, Fadli, Ela, Chung, Karen C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469540/ https://www.ncbi.nlm.nih.gov/pubmed/36096813 http://dx.doi.org/10.1186/s12913-022-08457-6 |
Ejemplares similares
-
Breast, Colorectal, Lung, Prostate, and Cervical Cancer Screening Prevalence in a Large Commercial and Medicare Advantage Plan, 2008–2020
por: Kim, Ashley, et al.
Publicado: (2022) -
Time duration and health care resource use during cancer diagnoses in the United States: A large claims database analysis
por: Gitlin, Matthew, et al.
Publicado: (2023) -
Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks versus Epoetin Alfa Every Week for Cancer Patients with Anemia due to the Effect of Concomitant Myelosuppressive Chemotherapy
por: McGarvey, November, et al.
Publicado: (2015) -
Factors in nephrologists’ decision to treat pre-dialysis CKD patients with vitamin D insufficiency and SHPT: A discrete choice experiment
por: Reddy, Anand C., et al.
Publicado: (2023) -
Post-infusion Costs Associated with Idecabtagene Vicleucel Treatment for Patients with Relapsed/Refractory Multiple Myeloma in the KarMMa Trial
por: McGarvey, November, et al.
Publicado: (2023)